Jonathan Mark Hopper has sold VCEL and made no open-market buys since Dec 2020

Hopper Jonathan Mark is a Person and serves as Chief Medical Officer at Vericel Corporation (NASDAQ: VCEL), where he helps lead the company’s medical and clinical strategy for its cell therapy business.( Vericel describes him as a seasoned industry executive with prior experience as a surgeon, and company filings indicate he was 63 years old as of the 2026 proxy statement.(

Before joining Vericel, Dr. Hopper held senior leadership roles across the life sciences sector, including Senior Medical Director, Orthopedic Clinical Development at Ferring Pharmaceuticals, where he led orthopedic clinical development strategy, and Vice President, Global Medical Director at Stryker.( He also has medical device regulatory experience from serving as a Senior Medical Officer at the UK Medicines and Healthcare products Regulatory Agency, and earlier served as Chief Medical Officer at Osiris Therapeutics; secondary profile information also indicates he has an MB ChB and additional business/healthcare training.(

Written by Perplexity from public sources.